Newer tetracycline derivatives: Synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 8, 2007, Pages 2372-2375

  Sriram, Dharmarajan ^a   Yogeeswari, Perumal ^a   Senchani, Geetha ^a   Banerjee, Debjani ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Anti HIV activity; Antimycobacterial activity; HIV 1 integrase; Tetracycline derivatives

Indexed keywords

INTEGRASE; LOMEFLOXACIN; MINOCYCLINE; ROLITETRACYCLINE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; ENZYME INHIBITION; EVALUATION; HUMAN; HUMAN CELL; MICROWAVE RADIATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; VIRUS REPLICATION;

ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; CELL LINE; CELL SURVIVAL; FLUOROQUINOLONES; HIV INTEGRASE INHIBITORS; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; SPECTRUM ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP; TETRACYCLINES; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM TUBERCULOSIS;

EID: 33947572695     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.11.055     Document Type: Article

References (16)

1. Mitsuya H., and Erickson J. In: Merigan T.C., Bartlett J.G., and Bolognesi D. (Eds). Textbook of AIDS Medicine (1999), Williams & Wilkins, Baltimore 751
2. Asante-Appiah E., and Skalka A.M. Adv. Virus Res. 52 (1999) 351
3. Esposito D., and Craigie R. Adv. Virus Res. 52 (1999) 319
4. Wu Y., and Marsh J.W. Science 293 (2001) 1503
5. De Clercq E. J. Med. Chem. 48 (2005) 1297
6. Pommier Y., Johnson A.A., and Marchand C. Nat. Rev. Drug Discovery 4 (2005) 236
7. Neamati N., Hong H., Sunder S., Milne G.W.A., and Pommier Y. Mol. Pharmacol. 52 (1997) 1041
8. Sriram D., Aubry A., Yogeeswari P., and Fischer L.M. Bioorg. Med. Chem. Lett. 16 (2006) 2982
9. Sriram D., Yogeeswari P., Srichakravarthy N., and Bal T.R. Biomed. Pharmacother. 59 (2005) 452
10. Mazumder A., Neamati N., Sundar S., Owen J., and Pommier Y. Retroviral integrase: a novel target in antiviral drug development and basic in vitro assays with purified enzyme. In: Kinchington D., and Schinazi R. (Eds). AntiViral Methods and Protocols Vol. 24 (1999), Humana, Totowa 327
11. National Committee for Clinical Laboratory Standards. Antimycobacterial susceptibility testing. Proposed standard M24-P. National Committee for Clinical Laboratory Standards, Villanova, Pa. 1990.
12. Dye C., Scheele S., Dolin P., Pathania V., and Raviglione M.C. JAMA 282 (1999) 677
13. Selwyn P.A., Hartel D., Wasserman W., and Drucker E. Am. J. Public Health 79 (1989) 1358
14. Daley C.L., Small P.M., and Schecter G.F. N. Engl. J. Med. 326 (1992) 231
15. Sriram D., and Yogeeswari P. Curr. Med. Chem. 10 (2003) 1689
16. 13C NMR, δ ppm: 13.1, 16.5, 23.5, 27.3, 28.4, 36.4, 40.6, 44.4, 47.2, 49.4, 50.0, 51.9, 61.1, 69.7, 74.4, 97.7, 106.1, 109.3, 112.1, 114.5, 119.8, 120.5, 121.3, 125.4, 126.6, 135.2, 139.5, 146.0, 146.3, 148.1, 150.3, 151.1, 159.1, 166.3, 174.9, 177.5, 183.1, 193.1, 193.4.